C-reactive protein: another addition to our armamentarium against tuberculosis?

Duncan Chanda¹, Maisa Kasanga², Raphael Chanda³, Frank Cobelens⁴

Affiliations

¹ Department of Medicine, Division of Infectious Diseases, University Teaching Hospital, Lusaka, Zambia; Adult Infectious Diseases Centre, University Teaching Hospital, Lusaka, Zambia; Department of Global Health and Amsterdam Institute for Global Health and Development, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, Netherlands. Electronic address: duncanchanda@gmail.com.
² Department of Pathology and Microbiology, University Teaching Hospital, Lusaka, Zambia; Department of Epidemiology and Biostatistics, School of Public Health, Zhengzhou University, Zhengzhou, China.
³ Department of Medicine, Division of Infectious Diseases, University Teaching Hospital, Lusaka, Zambia; Department of Pathology and Microbiology, University Teaching Hospital, Lusaka, Zambia.
⁴ Department of Global Health and Amsterdam Institute for Global Health and Development, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, Netherlands.

PMID: 37061298
DOI: 10.1016/S2214-109X(23)00175-4

Free article

Comment

C-reactive protein: another addition to our armamentarium against tuberculosis?

Duncan Chanda et al. Lancet Glob Health. 2023 May.

Free article

. 2023 May;11(5):e636-e637.

doi: 10.1016/S2214-109X(23)00175-4.

Authors

Duncan Chanda¹, Maisa Kasanga², Raphael Chanda³, Frank Cobelens⁴

Affiliations

¹ Department of Medicine, Division of Infectious Diseases, University Teaching Hospital, Lusaka, Zambia; Adult Infectious Diseases Centre, University Teaching Hospital, Lusaka, Zambia; Department of Global Health and Amsterdam Institute for Global Health and Development, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, Netherlands. Electronic address: duncanchanda@gmail.com.
² Department of Pathology and Microbiology, University Teaching Hospital, Lusaka, Zambia; Department of Epidemiology and Biostatistics, School of Public Health, Zhengzhou University, Zhengzhou, China.
³ Department of Medicine, Division of Infectious Diseases, University Teaching Hospital, Lusaka, Zambia; Department of Pathology and Microbiology, University Teaching Hospital, Lusaka, Zambia.
⁴ Department of Global Health and Amsterdam Institute for Global Health and Development, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, Netherlands.

PMID: 37061298
DOI: 10.1016/S2214-109X(23)00175-4

No abstract available

PubMed Disclaimer

Conflict of interest statement

We declare no competing interests.

Comment on

Use of point-of-care C-reactive protein testing for screening of tuberculosis in the community in high-burden settings: a prospective, cross-sectional study in Zambia and South Africa.
Ruperez M, Shanaube K, Mureithi L, Wapamesa C, Burnett MJ, Kosloff B, de Haas P, Hayes R, Fidler S, Gachie T, Schaap A, Floyd S, Klinkenberg E, Ayles H; TREATS study team. Ruperez M, et al. Lancet Glob Health. 2023 May;11(5):e704-e714. doi: 10.1016/S2214-109X(23)00113-4. Lancet Glob Health. 2023. PMID: 37061309

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information
Research Materials
- NCI CPTC Antibody Characterization Program

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

C-reactive protein: another addition to our armamentarium against tuberculosis?

Affiliations

C-reactive protein: another addition to our armamentarium against tuberculosis?

Authors

Affiliations

Conflict of interest statement

Comment on

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Research Materials